Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianfu Cough and Asthma Capsule is a Traditional Chinese Medicine (TCM) hospital preparation developed by The First Affiliated Hospital of Guangzhou Medical University. It is currently being evaluated in clinical trials for its efficacy in treating chronic obstructive pulmonary disease (COPD) complicated by pulmonary arterial hypertension (PH). The capsule is intended to be used as an adjunctive therapy alongside conventional Western medicine to improve respiratory function and reduce pulmonary artery pressure. As a TCM formulation, its mechanism likely involves multi-target effects including anti-inflammatory activity and modulation of pulmonary vascular remodeling, characteristic of its herbal components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tianfu cough and asthma capsule.